Answers are grounded in this paper and cite their sources.
YP modulates the PD-1/PD-L1 pathway to suppress inflammation in allergic airway inflammation, suggesting a novel treatment approach.
YP alleviates AAI by modulating the PD-1/PD-L1 pathway to restore Th17/Treg balance and suppress inflammation, thereby revealing its potential immunomodulatory mechanism.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: